ArticleFrontiers in cardiovascular medicine2023
Case report: New is not always better: treatment of non-bacterial thrombotic endocarditis.
Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.
- Cancer-associated Marantic Endocarditis and Direct Oral Anticoagulants: Case Report and Systematic Review.Current cardiology reviews · 2026Pooled it
- Acute ischemic stroke, active malignancy and non-bacterial thrombotic endocarditis: an exploratory prospective observational study.Scientific reports · 2026Observational
- Failure of oral anti-Xa to prevent non-bacterial thrombotic endocarditis in cancer: case report and literature review.European heart journal. Case reports · 2025Article
- Non-bacterial thrombotic endocarditis in ovarian cancer: A systematic review.Gynecologic oncology reports · 2025Review
- Clinical insights into nonbacterial thrombotic endocarditis in cancer patients: A case-based systematic review.ARYA atherosclerosis · 2025Review
- Perioperative Management of a Case of Trousseau Syndrome Accompanied by Aortic Valve Vegetation.Cureus · 2025Article
- Case Report: Unraveling a web of clots: marantic endocarditis as a paraneoplastic manifestation of lung cancer.Frontiers in oncology · 2025Article
- Exploring the Complexities of Non-Bacterial Thrombotic Endocarditis: Highlights from Literature and Case Studies.Journal of clinical medicine · 2024Review
- Non-bacterial thrombotic endocarditis in a patient with COVID.BMJ case reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An elderly female with metastatic adenocarcinoma of the lung and atrial fibrillation presented with multiple embolic strokes while on anticoagulation with Apixaban. After further investigation, a TEE showed lesions of non-bacterial thrombotic endocarditis on the mitral valve. A decision to switch the patient to LMWH for anticoagulation was then made and a follow-up TEE showed resolution of the NBTE. In this abstract, we show that heparin should remain as the anticoagulation agent of choice in the setting of NBTE associated with malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.